Bonanza of New Options for HR+/HER2- Breast Cancer

Patients with advanced HR-positive/HER2-negative breast cancer may benefit from practice-changing treatment options, as reported by Dr Javier Cort é s from ESMO 2016.

Source: Medscape Oncology - October 19, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts